TH110397A - The drug inhibits an increase in the amount of phosphorus in the blood. - Google Patents
The drug inhibits an increase in the amount of phosphorus in the blood.Info
- Publication number
- TH110397A TH110397A TH901001156A TH0901001156A TH110397A TH 110397 A TH110397 A TH 110397A TH 901001156 A TH901001156 A TH 901001156A TH 0901001156 A TH0901001156 A TH 0901001156A TH 110397 A TH110397 A TH 110397A
- Authority
- TH
- Thailand
- Prior art keywords
- increase
- blood
- phosphorus
- drug
- inhibit
- Prior art date
Links
- 210000004369 Blood Anatomy 0.000 title claims abstract 16
- 239000008280 blood Substances 0.000 title claims abstract 16
- OAICVXFJPJFONN-UHFFFAOYSA-N phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 title claims abstract 16
- 229910052698 phosphorus Inorganic materials 0.000 title claims abstract 16
- 239000011574 phosphorus Substances 0.000 title claims abstract 16
- 239000003814 drug Substances 0.000 title claims abstract 12
- 229940079593 drugs Drugs 0.000 title claims abstract 12
- 241000894006 Bacteria Species 0.000 claims abstract 6
- 239000004480 active ingredient Substances 0.000 claims abstract 5
- 239000002253 acid Substances 0.000 claims abstract 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims 2
- 235000014655 lactic acid Nutrition 0.000 claims 2
- 239000004310 lactic acid Substances 0.000 claims 2
- 241001134770 Bifidobacterium animalis Species 0.000 claims 1
- 241000186016 Bifidobacterium bifidum Species 0.000 claims 1
- 229940002008 Bifidobacterium bifidum Drugs 0.000 claims 1
- 241000186020 Bifidobacterium dentium Species 0.000 claims 1
- 241001608472 Bifidobacterium longum Species 0.000 claims 1
- 241000186015 Bifidobacterium longum subsp. infantis Species 0.000 claims 1
- 229940032049 Enterococcus faecalis Drugs 0.000 claims 1
- 241000194032 Enterococcus faecalis Species 0.000 claims 1
- 241000194031 Enterococcus faecium Species 0.000 claims 1
- 240000001046 Lactobacillus acidophilus Species 0.000 claims 1
- 229940039695 Lactobacillus acidophilus Drugs 0.000 claims 1
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 claims 1
- 240000004403 Lactobacillus casei Species 0.000 claims 1
- 240000006024 Lactobacillus plantarum Species 0.000 claims 1
- 241000194035 Lactococcus lactis Species 0.000 claims 1
- 235000014897 Streptococcus lactis Nutrition 0.000 claims 1
Abstract
DC60 (12/06/52) การประดิษฐ์นี้นำเสนอยายับยั้งการเพิ่มขึ้นของปริมาณฟอสฟอรัสในเลือดที่มีแบคทีเรียกรด แลตติคเป็นสารออกฤทธิ์สำคัญ ยายับยั้งการเพิ่มขึ้นของปริมาณฟอสฟอรัสในเลือดในการประดิษฐ์นี้ สามารถยับยั้งการเพิ่มขึ้นของฟอสฟอรัสในเลือดได้อย่างมาก ด้วยวิธีการให้ยาอย่างง่ายและมีความ ปลอดภัยสูง การประดิษฐ์นี้นำเสนอยายับยั้งการเพิ่มขึ้นของปริมาณฟอสฟอรัสในเลือดที่มีแบคทีเรียกรด แลตติคเป็นสารออกฤทธิ์สำคัญ ยายับยั้งการเพิ่มขึ้นของปริมาณฟอสฟอรัสในเลือดในการประดิษฐ์นี้ สามารถยับยั้งการเพิ่มขึ้นของฟอสฟอรัสในเลือดได้อย่างมาก ด้วยวิธีการให้ยาอย่างง่ายและมีความ ปลอดภัยสูง สิทธิบัตรยา DC60 (12/06/52) This invention offers a drug to inhibit the increase in blood phosphorus content of acid bacteria. Lattic is an important active ingredient. The drug inhibits the increase in blood phosphorus content in this invention. Can greatly inhibit the increase of phosphorus in the blood. With a simple and highly safe dosing method, the invention offers a drug to inhibit the increase in blood phosphorus content with acid bacteria. Lattic is an important active ingredient. The drug inhibits the increase in blood phosphorus content in this invention. Can greatly inhibit the increase of phosphorus in the blood. With a simple dosing method and high safety.
Claims (1)
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TH110397A true TH110397A (en) | 2011-09-15 |
| TH110397B TH110397B (en) | 2011-09-15 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Toscano et al. | A consumer’s guide for probiotics: 10 golden rules for a correct use | |
| ES2616334T3 (en) | Probiotics, secretory IgA and infection | |
| Ishizuka et al. | Effects of administration of Bifidobacterium animalis subsp. lactis GCL2505 on defecation frequency and bifidobacterial microbiota composition in humans | |
| HRP20130487A2 (en) | Probiotic formulation with apigenin and peppermint extract | |
| MX2011012069A (en) | Non-replicating micro-organisms and their immune boosting effect. | |
| PH12018502042A1 (en) | Use of probiotics in the treatment and/or prevention of psoriasis | |
| RU2007106038A (en) | COMPOSITION BASED ON PROBIOTIC BACTERIA AND ITS APPLICATION IN PREVENTION AND / OR TREATMENT OF RESPIRATORY PATHOLOGIES AND / OR INFECTIONS AND IN IMPROVING THE INTESTINAL FUNCTION | |
| NZ593708A (en) | Compositions comprising probiotic and prebiotic components and mineral salts, with lactoferrin | |
| RU2014107770A (en) | COMPOSITION COMPRISING N-ACETYLCYSTEINE AND / OR microencapsulated protected from gastric acid lysozyme IN COMBINATION WITH probiotic bacteria capable of reducing OWN BARRIER EFFECT stomach which expire during the treatment of gastric hyperacidity FARMALOGICHESKOGO | |
| ITMI20131473A1 (en) | METHOD OF ASSESSING THE EFFECTS OF A COMPOSITION INCLUDING MICRO-ORGANISMS ON THE INTESTINAL MICROBIOTE | |
| WO2009013709A3 (en) | Zinc-enriched biomass, method for the preparation thereof and pro-biotic, cosmetic, dietary and nutraceutic products comprising the same | |
| PH12019500123A1 (en) | Use of probiotics in the treatment and/or prevention of atopic dermatitis | |
| RU2013126609A (en) | EXTRUDED NON-REPLICATING PROBIOTIC MICRO-ORGANISMS AND THEIR HEALTH BENEFITS | |
| JP2008539776A5 (en) | ||
| Bunesova et al. | Comparison of mupirocin-based media for selective enumeration of bifidobacteria in probiotic supplements | |
| Kalliomäki et al. | Positive interactions with the microbiota: probiotics | |
| FI20075539L (en) | Lactic acid bacteria with proinflammatory properties | |
| WO2011073769A3 (en) | Conjugated linoleic acid-producing strains of probiotic bacteria and use thereof for the preparation of a food, dietetic or pharmaceutical composition | |
| TH110397A (en) | The drug inhibits an increase in the amount of phosphorus in the blood. | |
| Vankerckhoven et al. | Establishment of the PROSAFE collection of probiotic and human lactic acid bacteria | |
| WO2012021016A3 (en) | Lactobacillus strain having anti-cancer activity and anti-cancer activity composition including same as active ingredient | |
| Kabiri et al. | Inhibitiory properties of cytoplasmic extract of Lactobacilli isolated from common carp intestine on human chronic myelocytic leukemia K562 cell line: an in vitro study. | |
| AR071905A1 (en) | METHOD FOR REDUCING BORBORIGMS THROUGH THE ADMINISTRATION OF A BIFIDOBACTERIUM BACTERIA | |
| UA45164U (en) | Method for producing symbiter-premium probiotic | |
| Bilginer et al. | Probiotics and in vitro tests used for their determination. |